SCHEMBL7038310

SCHEMBL7038310

Cc1nc2cc(Nc3ccc(C(=NO)c4ccccc4C)c(Cl)c3)ccc2s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.48
MAPK14 Q16539 7/20 0.46
MAPK13 O15264 6/20 0.46
MAPK12 P53778 6/20 0.46
MAPK11 Q15759 6/20 0.46
POLB P06746 2/20 0.39
PKM P14618 1/20 0.39
VDR P11473 1/20 0.39
TP53 P04637 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
MAPT P10636 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 1/20 0.38
TRPV1 Q8NER1 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7032053 0.85 MAPK13 (0.65) KMT2AMAPK14MAPK13MAPK12MAPK11
SCHEMBL7037527 0.85 KMT2A (0.50) KMT2AMAPK14MAPK13MAPK12MAPK11
SCHEMBL7040555 0.83 NPC1 (0.50) KMT2AMAPK14MAPK13MAPK12MAPK11
SCHEMBL1907236 0.81 MAPK14 (0.67) KMT2AMAPK14MAPK13MAPK12MAPK11
SCHEMBL1904902 0.80 MAPK14 (0.59) KMT2AMAPK14MAPK13MAPK12MAPK11
SCHEMBL7035645 0.79 MAPK14 (0.55) KMT2AMAPK14MAPK13MAPK12MAPK11
SCHEMBL7038381 0.79 NPC1 (0.54) MAPK14MAPK13MAPK12MAPK11POLB
SCHEMBL7036523 0.78 MAPK14 (0.51) KMT2AMAPK14MAPK13MAPK12MAPK11
SCHEMBL7038347 0.78 KDR (0.47) MAPK14MAPK13MAPK12MAPK11POLB
SCHEMBL1905870 0.78 MAPK14 (0.56) KMT2AMAPK14MAPK13MAPK12MAPK11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289958-A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) Leo Pharma A/S (DK) 2003-03-12 EP claimed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US claimed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US claimed
WO-2001090074-A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-11-29 WO claimed
EP-1289958-A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) Leo Pharma A/S (DK) 2003-03-12 EP disclosed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US disclosed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US disclosed
WO-2001090074-A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha IL1B, IL1A, NFKBIA KMT2A 4565/4885MAPK14 625/4885MAPK13 1908/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.